Literature DB >> 16938544

The affymetrix GeneChip platform: an overview.

Dennise D Dalma-Weiszhausz1, Janet Warrington, Eugene Y Tanimoto, C Garrett Miyada.   

Abstract

The intent of this chapter is to provide the reader with a review of GeneChip technology and the complete system it represents, including its versatility, components, and the exciting applications that are enabled by this platform. The following aspects of the technology are reviewed: array design and manufacturing, target preparation, instrumentation, data analysis, and both current and future applications. There are key differentiators between Affymetrix' GeneChip technology and other microarray-based methods. The most distinguishing feature of GeneChip microarrays is that their manufacture is directed by photochemical synthesis. Because of this manufacturing technology, more than a million different probes can be synthesized on an array roughly the size of a thumbnail. These numbers allow the inclusion of multiple probes to interrogate the same target sequence, providing statistical rigor to data interpretation. Over the years the GeneChip platform has proven to be a reliable and robust system, enabling many new discoveries and breakthroughs to be made by the scientific community.

Mesh:

Year:  2006        PMID: 16938544     DOI: 10.1016/S0076-6879(06)10001-4

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  38 in total

Review 1.  Integrating global gene expression analysis and genetics.

Authors:  Charles R Farber; Aldons J Lusis
Journal:  Adv Genet       Date:  2008       Impact factor: 1.944

Review 2.  Expression profiling of microRNA using oligo DNA arrays.

Authors:  Chang-Gong Liu; Riccardo Spizzo; George Adrian Calin; Carlo Maria Croce
Journal:  Methods       Date:  2008-01       Impact factor: 3.608

Review 3.  Basic concepts of microarrays and potential applications in clinical microbiology.

Authors:  Melissa B Miller; Yi-Wei Tang
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

4.  Nano-plasmonics and electronics co-integration in CMOS enabling a pill-sized multiplexed fluorescence microarray system.

Authors:  Lingyu Hong; Hao Li; Haw Yang; Kaushik Sengupta
Journal:  Biomed Opt Express       Date:  2018-10-26       Impact factor: 3.732

5.  Mapping targetable sites on human telomerase RNA pseudoknot/template domain using 2'-OMe RNA-interacting polynucleotide (RIPtide) microarrays.

Authors:  Lourdes Gude; Shaunna S Berkovitch; Webster L Santos; Peter S Kutchukian; Adam R Pawloski; Robert Kuimelis; Glenn McGall; Gregory L Verdine
Journal:  J Biol Chem       Date:  2012-03-26       Impact factor: 5.157

6.  A statistical method for excluding non-variable CpG sites in high-throughput DNA methylation profiling.

Authors:  Hailong Meng; Andrew R Joyce; Daniel E Adkins; Priyadarshi Basu; Yankai Jia; Guoya Li; Tapas K Sengupta; Barbara K Zedler; E Lenn Murrelle; Edwin J C G van den Oord
Journal:  BMC Bioinformatics       Date:  2010-05-05       Impact factor: 3.169

7.  Application of equilibrium models of solution hybridization to microarray design and analysis.

Authors:  Raad Z Gharaibeh; Joshua M Newton; Jennifer W Weller; Cynthia J Gibas
Journal:  PLoS One       Date:  2010-06-10       Impact factor: 3.240

8.  A decreased ratio of laminin-332 beta3 to gamma2 subunit mRNA is associated with poor prognosis in colon cancer.

Authors:  Cherise M Guess; Bonnie J Lafleur; Brandy L Weidow; Vito Quaranta
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-04-21       Impact factor: 4.254

Review 9.  Oligonucleotide microarray technology and its application to Mycobacterium avium subsp. paratuberculosis research: a review.

Authors:  Radka Pribylova; Petr Kralik; Ivo Pavlik
Journal:  Mol Biotechnol       Date:  2009-01-06       Impact factor: 2.695

10.  Cytoplasmic acidification and the benzoate transcriptome in Bacillus subtilis.

Authors:  Ryan D Kitko; Rebecca L Cleeton; Erin I Armentrout; Grace E Lee; Ken Noguchi; Melanie B Berkmen; Brian D Jones; Joan L Slonczewski
Journal:  PLoS One       Date:  2009-12-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.